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The ISSCR annual meeting series is a cornerstone of the society. Developed by the Annual Meeting Program
Committee, each meeting covers a broad spectrum of high-end stem cell research, drawing on the local
environment and taking on its own individual feel and emphasis.Greetings and welcome to the Sixth International Society for
Stem Cell Research (ISSCR) Annual Meeting, in Philadelphia,
PA, USA. This year’s meeting promises to be as exciting as the
previous meetings, but with its own flavor. I have been privileged
to be the Chair of the Annual Meeting Program Committee for
this year’s meeting: a task that I took on with a high degree of
expectation and interest. Successful assembly of the program
would, of course, not have been possible without the enthusias-
tic participation of members of the Program Committee (Table 1),
Dr. George Daley and the folks in the ISSCR administration, par-
ticularly, Michael Hagedorn and Nancy Witty. Michael’s involve-
ment, especially, ensured that everything was accomplished in
a proper and timely manner (even though not all scientists are
renowned for their abilities to rigorously adhere to deadlines).
One of the challenges that the Program Committee Chair faces
is providing a general ‘‘flavor’’ for the meeting. This, in turn, al-
lows the Chair to incorporate, as much as possible, his or her
overall vision of the stem cell field, where the field is heading,
and where the field should (or perhaps should not) be heading.
As is clearly the case in an area of research as rapidly expanding
as stem cells, it is not always possible to adequately cover all (or
even most) of the important topics. My apologies to the many
outstanding investigators who may feel that their research inter-
ests have not been sufficiently represented. This in no way re-
flects a lack of interest or appreciation on the part of the Program
Committee. Please allow me to provide you with some aspects
of my thinking as I first approached putting together this year’s
meeting program.First, stem cell biology has emerged as a vital part of the much
broader area of developmental biology. In fact, it is becoming
clear that the development and physiological function of many
tissues previously not considered among the classical stem
cell systems involve stem cells. Therefore, we have dedicated
two plenary sessions that together should stimulate further think-
ing along these lines. The meeting opens with an outstanding
lineup of talks that will set a developmental biology context for
the entire meeting. The importance of providing this context
has also been pointed out by participants of previous ISSCR
meetings. The second plenary session takes the somewhat op-
posite viewpoint: that is, it is focused on the most ‘‘mature,’’
most intensively studied, and archetypical stem cell system, he-
matopoietic stem cells. Indeed, it is fair to say that most, if not all,
properties now generally ascribed to stem cells were first de-
fined in the hematopoietic system. Thus, it seemed reasonable
to devote an entire session to this system, as a way to address
what we really understand about the control of stem cell
properties after five decades of research. In addition, hemato-
poietic stem cell transplantation is the basis for therapeutic inter-
vention directed against numerous diseases. Therefore, the
study of hematopoietic stem cells is a clear paradigm for what
we all hope will be reflected in clinical applications for other
stem cell systems. We hope also to give pause to those who
see rapid development of more general stem cell-based trans-
plantation therapies, as they consider the full extent of intensive
research that has gone into understanding the hematopoietic
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ISSCR: Committee ForumSecond, a growing theme in the postgenomic era is that mul-
tidisciplinary approaches, often involving engineering disciplines
and novel technologies, are most effective in arriving at a deep
level of biological understanding. This is also the case for stem
cell research. An effort has been made to present some of these
approaches at the meeting, and we hope that this will stimulate
participants to consider how these may apply to their own re-
search. As one example, a new discipline called synthetic biol-
ogy has suggested that cells can be programmed with artificial
circuitry to promote defined cell-fate outcomes. This is intro-
duced during this year’s meeting in Concurrent Session 1, Novel
Emerging Technologies.
Third, we have devoted significant attention to clinical transla-
tion of stem cell research, alongside the ethical issues that arise
in conjunction with clinical applications. Explored both in a ple-
nary session on clinical translation and integrated into concurrent
sessions, we hope that this will provide a sense of how, when,
and in what contexts stem cell research will begin to have a broad
impact on clinical medicine. This theme merges very well with the
expanding field of cancer stem cells, followed by adult stem cell
physiology, also highlighted in plenary sessions.552 Cell Stem Cell 2, June 2008 ª2008 ISSCRFourth, we have certainly not forgotten embryonic stem cells
and their vast biological abilities and critical key properties. Fi-
nally, the issue of reprogramming of nonembryonic cells into en-
tities with embryonic stem cell-like properties ends our roster of
plenary sessions. A focus here is also on the epigenetics of stem
cells. These novel technologies represent a true sea change in
the field of stem cell research, and therefore it is fitting to close
this year’s meeting on this note.
All plenary sessions are supplemented with concurrent ses-
sions to expand on the broad topics they introduce. We hope
that the concurrent sessions, which include 49 speakers se-
lected from the more than 1300 submitted abstracts, will pro-
vide the latest and greatest research results and stimulate
much discussion. On a final note, this year’s roster of speakers
was also chosen with a genuine effort to include as many young
investigators as possible and those who have not previously
presented their research results at the ISSCR meeting.
Along with the entire Program Committee, I am extremely ex-
cited about the content of the meeting. We certainly hope
that you will find much of interest and much to stimulate your
intellect.
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